DiaMedica Therapeutics, Inc. (DMAC)
8.79
-0.54
(-5.79%)
USD |
NASDAQ |
Nov 13, 16:00
8.79
0.00 (0.00%)
After-Hours: 19:59
DiaMedica Therapeutics EPS Diluted (Quarterly) : -0.1881 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1881 |
| March 31, 2026 | -0.1867 |
| December 31, 2025 | -0.1655 |
| September 30, 2025 | -0.1737 |
| June 30, 2025 | -0.1792 |
| March 31, 2025 | -0.1799 |
| December 31, 2024 | -0.1845 |
| September 30, 2024 | -0.1467 |
| June 30, 2024 | -0.1345 |
| March 31, 2024 | -0.1357 |
| December 31, 2023 | -0.136 |
| September 30, 2023 | -0.1178 |
| June 30, 2023 | -0.1639 |
| March 31, 2023 | -0.1993 |
| December 31, 2022 | -0.1418 |
| September 30, 2022 | -0.1157 |
| June 30, 2022 | -0.127 |
| March 31, 2022 | -0.1327 |
| December 31, 2021 | -0.1227 |
| September 30, 2021 | -0.1812 |
| June 30, 2021 | -0.1743 |
| March 31, 2021 | -0.193 |
| December 31, 2020 | -0.224 |
| September 30, 2020 | -0.1913 |
| June 30, 2020 | -0.175 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.185 |
| December 31, 2019 | -0.2065 |
| September 30, 2019 | -0.2039 |
| June 30, 2019 | -0.2061 |
| March 31, 2019 | -0.272 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | -0.177 |
| June 30, 2018 | -0.2218 |
| March 31, 2018 | -0.0992 |
| December 31, 2017 | -0.20 |
| September 30, 2017 | -0.20 |
| June 30, 2017 | -0.20 |
| March 31, 2017 | -0.20 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | -0.1533 |
| June 30, 2016 | -0.1551 |
| March 31, 2016 | -0.1456 |
| December 31, 2015 | -0.1288 |
| September 30, 2015 | -0.0697 |
| June 30, 2015 | -0.0976 |
| March 31, 2015 | -0.1612 |
| December 31, 2014 | -0.3522 |
| September 30, 2014 | -0.3675 |
| June 30, 2014 | -0.3668 |
| March 31, 2014 | -0.7252 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Nektar Therapeutics | -1.229 |
| Fortress Biotech, Inc. | -0.0779 |
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.14M |
| Total Expenses (Quarterly) | 10.14M |
| Enterprise Value | 459.81M |
| Earnings Yield | -8.12% |
| Normalized Earnings Yield | -8.123 |